How Seattle Genetics Made The Forbest Fastest Growing Busines List

Forbes is one of the most respected names in mainstream society today. The company has a reputable reputation, class, prestige, and are very ethical. Every year the company reports on the fastest growing businesses in the nation and a bit of information on how they made the list. For 2015 Biotech Giant Seattle Genetics of Bothell, Washington made the top 100. Seattle Genetics has come along way over the years, but the company has stayed on track and is now the world’s leader in antibody based therapies. That’s right! These therapies are highly advanced especially when being compared to the drugs before them. It’s like they have intelligence of their own once inside the body and here is how it works.

Cancerous Cells within the body will spread if not treated. What makes antibody based therapy so great that the delivery system has a more direct approach when fighting cancer. Antibody Drug Conjugates are the specific name here that falls under antibody based therapy. Deadly cancer cells get a shot of cell killing agents in a direct fashion all while sparing the other non-targeted cells. It’s simply genius and this what Seattle Genetics develops and commercializes. With sales of $226 Million in the U.S. and Canada alone, imagine what those numbers will be when the drug reaches worldwide. CEO and President Clay Siegall is in charge of this ship and he is one of the major reasons for the company’s success. Dr. Clay Siegall is known in the industry a philanthropist, scientist, and doctor. He’s been in the business for many decades and has worked for prominent names such as Bristol Myers Squibb, The National Cancer Institute, and The National Institute of Health.

Dr. Clay Siegall has this strong passion for helping others even though he’s not a household name. The common goal is eradicate this deadly disease (via) advanced breakthrough therapies and Seattle Genetics is steering the ship to success.

Leave a Reply

Your email address will not be published. Required fields are marked *